Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups
Status
Status :
Completed
Type of study
Phase II
Min. Age
55
Years old
Max. Age
90
Years old
Gender
All
Therapeutic area :
Mental Health
Disease :
Cognitive impairment
Study medication :
V0191
Phase :
Phase II
Start Date :
16 October 2007
End date :
16 December 2009
Study ID :
V00191 PO 202
EudraCT/CTIS number :
2007-001975-12
Send by email